Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

ZUG, Switzerland, May 29, 2026 (GLOBE NEWSWIRE) -- Conference call today at 4:30 pm ET

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.